Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 2:44 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2233–2256 of 8,698 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Longitudinal Studies Clear all

Conditions: Heart Failure
Interventions: CardioMEMS; Device
Lead sponsor: STAVROS G DRAKOS; Other
Eligibility: 18 Years to 60 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Lexington, Kentucky • Falls Church, Virginia

Conditions: Aging, Mortality, All-cause Mortality, Life Expectancy, Cardiovascular Diseases, Neoplasms, Cognitive Dysfunction, Metabolic Syndrome, Frailty, Musculoskeletal Disease, Neurodegenerative Disease, Dementia, Activities of Daily Living, Health Related Quality of Life, Environmental Exposure, Occupational Diseases, Health Equity, Social Determinants of Health, Physical Disability
Interventions: Multi-Domain Ecological and Clinical Data Linkage; Other
Lead sponsor: Longevity Metrics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 1,000,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2099
U.S. locations: 1
States / cities: Boulder, Colorado

Conditions: Alcohol Use Disorder
Interventions: High-Intensity Cue, Low-Intensity Cue; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Rotator Cuff Tear, Rotator Cuff Tendinitis
Interventions: Adipose Derived Regenerative Cells, Corticosteroid; Device · Drug
Lead sponsor: InGeneron, Inc.; Industry
Eligibility: 30 Years to 75 Years
Enrollment: 168 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2025
U.S. locations: 14
States / cities: Phoenix, Arizona • La Mesa, California • Pasadena, California + 11 more

Conditions: Heart Failure, Obesity, Weight Loss, Heart Failure With Preserved Ejection Fraction
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 40 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Amyloidosis, Paraproteinemias, Cardiomyopathies
Interventions: Amyloidosis, Cardiac Amyloidosis; Other
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years to 85 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Uterine Fibroid
Interventions: NA- no intervention; Other
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older · Female only
Enrollment: 700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 4
States / cities: San Francisco, California • Detroit, Michigan • Rochester, Minnesota + 1 more

Conditions: Diabetes Mellitus, Type 2
Interventions: Not listed
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 5 Years to 99 Years
Enrollment: 12,647 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1976
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Influenza
Interventions: CAIV-T, TIV; Biological · Other
Lead sponsor: MedImmune LLC; Industry
Eligibility: 6 Months to 36 Months
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2006
U.S. locations: 5
States / cities: Layton, Utah • Ogden, Utah • Pleasant Grove, Utah + 2 more

Conditions: Muscle
Interventions: Blend, Whey, Placebo; Dietary Supplement
Lead sponsor: DuPont Nutrition and Health; Industry
Eligibility: 18 Years to 35 Years · Male only
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Euvolemic Hyponatremia, Hypervolemic Hyponatremia
Interventions: Not listed
Lead sponsor: Otsuka America Pharmaceutical; Industry
Eligibility: 18 Years and older
Enrollment: 5,028 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 72
States / cities: Azusa, California • Inglewood, California • Los Angeles, California + 58 more

Conditions: Autoimmune Diseases, Epilepsy, Autonomic Dysfunction, Inflammatory Bowel Diseases
Interventions: Vagal nerve stimulation (VNS); Device
Lead sponsor: University of Louisville; Other
Eligibility: 0 Years to 60 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 4
States / cities: Louisville, Kentucky • Houston, Texas • Salt Lake City, Utah

Conditions: Preoperative Care, Surgery--Complications, Myocardial Infarction
Interventions: Not listed
Lead sponsor: Centre hospitalier de l'Université de Montréal (CHUM); Other
Eligibility: 45 Years and older
Enrollment: 15,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 5
States / cities: Winston-Salem, North Carolina • Cleveland, Ohio • Houston, Texas

Conditions: Bleeding Cardiac Surgery Patients
Interventions: Octaplex, Frozen Plasma Product, Human; Drug
Lead sponsor: Octapharma; Industry
Eligibility: 18 Years and older
Enrollment: 420 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 2
States / cities: Durham, North Carolina • Oklahoma City, Oklahoma

Conditions: Diabetic Foot Ulcers
Interventions: EpiFix Mesh; Other
Lead sponsor: MiMedx Group, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Roanoke, Virginia

Conditions: Vitreo-Retinal Surgery
Interventions: Dextenza 0.4Mg Ophthalmic Insert, Topical Prednisolone; Drug
Lead sponsor: Patrick R. Oellers, MD; Network
Eligibility: Not listed
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Liverpool, New York

Conditions: SCN8A Developmental and Epileptic Encephalopathy Syndrome
Interventions: NBI-921352; Drug
Lead sponsor: Neurocrine Biosciences; Industry
Eligibility: 2 Years to 22 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 4
States / cities: San Francisco, California • Washington D.C., District of Columbia • Rochester, New York + 1 more

Conditions: Bone Regeneration
Interventions: GUIDOR® membrane with FDBA, GUIDOR® membrane, Bio-Gide® membrane with FDBA; Device
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 21 Years to 75 Years
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 2
States / cities: Los Angeles, California • Chapel Hill, North Carolina

Conditions: Presbyopia
Interventions: Mitomycin C, Raindrop Near Vision Inlay; Drug · Device
Lead sponsor: Fichte, Endl & Elmer Eyecare; Other
Eligibility: 41 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Amherst, New York

Conditions: Sleep Initiation and Maintenance Disorders, Pain
Interventions: Cyclobenzaprine; Drug
Lead sponsor: Lynn Henry; Other
Eligibility: 18 Years and older · Female only
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: White Noise, Sleep, Sleep Fragmentation, Sleep Duration
Interventions: Active white noise, Inactive white noise; Device
Lead sponsor: Scripps Health; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Clostridium Difficile
Interventions: Not listed
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 4
States / cities: Minneapolis, Minnesota • Rochester, Minnesota • Philadelphia, Pennsylvania + 1 more

Conditions: Peripheral Artery Disease
Interventions: Lutonix Drug Coated Balloon; Device
Lead sponsor: C. R. Bard; Industry
Eligibility: 18 Years and older
Enrollment: 657 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 39
States / cities: Los Angeles, California • Oceanside, California • Orange, California + 32 more

Conditions: GIST
Interventions: EUS-TCB needle (QuickCore) standard of care, EUS-Guided biopsy needle (ProCore); Device
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Indianapolis, Indiana

Search by objective public record fields.

TARGET-LOAD Pilot Study Comparing Hemodynamics-guided LVAD Unloading Vs. Standard of Care

Human Observatory Study

Enhancing Prospective Thinking in Early Recovery (NERF)

Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears

WeighT LOSS Surgery and Comprehensive Cardiometabolic Responses to to EXercise

Prospective Identification of Cardiac Amyloidosis by Cardiac Magnetic Resonance Imaging

Ascertaining Longterm Outcomes of Fibroid Treatments

Prospective Studies of the Natural History of Diabetes Mellitus and Its Complications in the Gila River Indian Community

Study to Evaluate the Immune Responses of Trivalent Cold-Adapted Influenza Vaccine (CAIV-T) Compared With (TIV)

Effect of Protein Blend Supplementation During Exercise Training on Muscle Growth and Strength

Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia

VNS Prospective Neuromodulation of Immune and Gastrointestinal Systems

Vascular Events In Patients Undergoing Same-day Noncardiac Surgery (VALIANCE) Study

Active-control Randomized Trial Comparing 4-factor Prothrombin Complex Concentrate With Frozen Plasma in Cardiac Surgery

dHACM Mesh In the Treatment of Diabetic Foot Ulcers

DEXTENZA for the Treatment of Postoperative Pain and Inflammation Following Vitreo-retinal Surgery

Extension Study to Evaluate How Safe and Tolerable NBI-921352 is as an Adjunctive Therapy for Participants With SCN8A-DEE

Prospective, Comparative Assessment of Alveolar Bone Augmentation Using GUIDOR® Membrane in the Bound Edentulous Space

A Prospective Study to Evaluate the Raindrop Near Vision Inlay With Mitomycin C

Pilot Study of Cyclobenzaprine for Treatment of Sleep Disturbance in Aromatase Inhibitor-treated Breast Cancer Patients

Sleepless at Scripps: An Inpatient White Noise Study

Observational Study of C. Diff in Post-Transplant Patients

LEVANT 2 Continuation Registry of the Lutonix® Drug Coated Balloon (DCB)

Evaluation of a New EUS-guided Needle (ProCore) Comparing to EUS-TCB Needle (Quick-Core)